What is Inhaler Devices?
Inhaler devices are used to deliver medicines for asthma which delivers medicines to the lungs and airways. The inhaler devices are available in shapes & sizes prescribed by doctors or asthma educators. It is mainly used to prevent diseases of the respiratory airways like chronic obstructive pulmonary diseases or cystic fibrosis. The device is available in three types such as pressurized metered-dose inhalers, dry powder inhalers, and soft mist inhalers.
The market study is broken down by Type (Pressurized Metered Dose Inhaler (pMDI), Dry Powder Inhaler (DPI) and Soft Mist Inhaler (SMI)), by Application (Residential, Hospital, Clinic and Respiratory Care Centers) and major geographies with country level break-up.
Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
3M (United States), Gerresheimer AG (Germany), Boehringer Ingelheim International GmbH (Germany), Cipla Limited (India), Cohero Health, Inc (United States), Iconovo AB (Sweden), Teva Pharmaceutical Industries Ltd. (Israel), GlaxoSmithKline (United Kingdom), MannKind Corporation (United States) and Beximco Pharmaceuticals Ltd (Bangladesh) are some of the key players that are part of study coverage.
AdvanceMarketAnalytics has segmented the market of Global Inhaler Devices market by Type, Application and Region.
On the basis of geography, the market of Inhaler Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Sales Channel, the sub-segment i.e. Online will boost the Inhaler Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Adults will boost the Inhaler Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Leaders and their expansionary development strategies
On 21st September 2020, Teva Launches Two Digital Inhalers in the U.S., AirDuo Digihaler (fluticasone propionate and salmeterol) Inhalation Powder, and ArmonAir Digihaler (fluticasone propionate) Inhalation Powder. AirDuo Digihaler is a prescription medicine used to control symptoms of asthma and to prevent symptoms such as wheezing in people 12 years of age and older.
On 5th August 2019, MannKind Corporation and One Drop today announced that they have signed a collaborative agreement that is intended to integrate MannKindís BluHale accessory device into the One Drop platform. BluHale is a Bluetooth-connected accessory that attaches to the Afrezza inhaler and is designed to convey real-time information about inhalation effort and insulin dose.
"It is important to note that Metered Dose Inhalers and Actuators are reviewed in the Center for Drug Evaluation and Research (CDER), where Nebulizers and Spacers, as well as Metered Dose Inhalers intended for a ventilator circuit, are reviewed in the Center for Devices and Radiological Health (CDRH). Since there are a variety of medical products in the category of nebulizers and MDIS, it is not possible to develop an exhaustive guidance document that will cover all modalities in most applications. However, the general principles regarding the information to be contained in a 510(k) should be valid for all cases."
- Increasing Consumption of Metered Dose Inhaler Devices in Different Sizes and Shapes
- Growing Number of Patients with the Respiratory Airway Disease
- Need for the Portable and Compact Inhaling Devices
- Technological Advancements in the Inhaling Devices
- Rising Availability of Inhaler Devices in E-commerce Sites
- Materials Used in the Production and Packaging of Inhaling Devices Affecting the Environment
- Stiff Competition in the Inhaling Devices Market
Key Target Audience
Inhaler Devices Manufacturers, Inhaler Devices International Traders, Inhaler Devices Distributors & Suppliers, Research and Development Institutes, Potential Investors, Regulatory Bodies and Others
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.
Frequently Asked Questions (FAQ):1. What all players are profiled in the study?
The standard version of the report profiles players such as 3M (United States), Gerresheimer AG (Germany), Boehringer Ingelheim International GmbH (Germany), Cipla Limited (India), Cohero Health, Inc (United States), Iconovo AB (Sweden), Teva Pharmaceutical Industries Ltd. (Israel), GlaxoSmithKline (United Kingdom), MannKind Corporation (United States) and Beximco Pharmaceuticals Ltd (Bangladesh) etc.2. Can we have customized study for Inhaler Devices Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.3. What would be the Market Size of Inhaler Devices Market by 2027?
Analysts at AMA estimates Inhaler Devices Market to reach USD Million by 2027.